首页> 外文期刊>Journal of drug targeting >Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.
【24h】

Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.

机译:使用聚合物沉淀抑制剂来改善水溶性差的药物的吸收:实用性的机械基础。

获取原文
获取原文并翻译 | 示例
           

摘要

The inclusion of certain polymers within solid dispersion or lipid-based formulations can maintain drug supersaturation after dispersion and/or digestion of the vehicle, leading to improvements in bioavailability and variability in exposure. This review presents an overview of the fundamental principles that underpin drug precipitation mechanisms, describes the mechanisms by which precipitation may be inhibited, discusses the methods that can be used to identify polymeric precipitation inhibitors (PPIs), and summarizes current literature evidence of the most effective PPIs. Preliminary data from our laboratory is also presented, which describes the precipitation inhibition behavior of 53 polymeric materials using supersaturated solutions of danazol as a model, poorly water-soluble drug. These studies identify a group of PPIs with superior precipitation inhibition qualities, the majority of which are cellulose-based. These new results in combination with previous published data indicate that PPIs represent an appealing new technology with the potential to improve drug absorption for poorly water-soluble drugs. The molecular determinants of polymer utility, however, remain relatively poorly understood, although the cellulose derivates appear, in general, to provide the most benefit. More detailed studies are therefore required to define the parameters that most effectively predict and quantify the drug-polymer relationships that control precipitation inhibition.
机译:在固体分散体或基于脂质的制剂中包含某些聚合物可以在媒介物分散和/或消化后维持药物过饱和,从而导致生物利用度和暴露变异性的改善。这篇综述概述了支持药物沉淀机制的基本原理,描述了抑制沉淀的机制,讨论了可用于鉴定聚合物沉淀抑制剂(PPI)的方法,并总结了目前最有效的文献证据。 PPI。还提供了来自我们实验室的初步数据,该数据描述了以达那唑的过饱和溶液为模型的水溶性差的药物对53种聚合材料的沉淀抑制行为。这些研究确定了一组具有优异沉淀抑制质量的PPI,其中大多数是基于纤维素的。这些新结果与先前发表的数据相结合表明,PPI是一种有吸引力的新技术,具有改善水溶性差的药物吸收的潜力。然而,尽管一般来说纤维素衍生物似乎提供了最大的益处,但是对聚合物用途的分子决定因素仍然知之甚少。因此,需要更详细的研究来定义最有效地预测和量化控制沉淀抑制的药物-聚合物关系的参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号